Intestinal drug transporter expression and the impact of grapefruit juice in humans (Q40184411)

18 September 2017

Intestinal drug transporter expression and the impact of grapefruit juice in humans (English)

1 reference

18 September 2017

Glaeser H

1

1 reference

18 September 2017

Bailey DG

2

1 reference

18 September 2017

Dresser GK

3

1 reference

18 September 2017

Gregor JC

4

1 reference

18 September 2017

Schwarz UI

5

1 reference

18 September 2017

McGrath JS

6

1 reference

18 September 2017

Jolicoeur E

7

1 reference

18 September 2017

Lee W

8

1 reference

18 September 2017

Leake BF

9

1 reference

18 September 2017

Tirona RG

10

1 reference

18 September 2017

Kim RB

11

1 reference

18 September 2017

language of work or name

English

0 references

publication date

10 January 2007

1 reference

Clinical Pharmacology & Therapeutics

18 September 2017

1 reference

18 September 2017

81

1 reference

18 September 2017

3

1 reference

18 September 2017

362-370

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100056

18 September 2017

0 references

cites work

The drug efflux-metabolism alliance: biochemical aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Importance of P-glycoprotein for drug disposition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Functional interaction of intestinal CYP3A4 and P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Interaction of citrus juices with felodipine and nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Grapefruit juice-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Interactions between grapefruit juice and cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

P-glycoprotein-mediated intestinal and biliary digoxin transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

First-pass metabolism of cyclosporin by the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Grapefruit juice ingestion significantly reduces talinolol bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100056

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100056

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference